logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Alessandro Armuzzi

irccs humanitas research hospital

71H指数
970论文数
2.5W被引数
收录论文 394
发表时间
logo
Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease—A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)真实世界中乌帕替尼在克罗恩病患者中的有效性和安全性——一项来自意大利炎症性肠病研究组（IG-IBD）的多中心前瞻性研究
errALIMENTARY PHARMACOLOGY & THERAPEUTICS
IF6.7
err2026-09-11
err0
PREAI
errBrigida Barberio; Ferdinando D'Amico; Lucrezia Laterza; Cristina Bezzio; Gabriele Dragoni; Anna Viola; Alessia Todeschini; Mariabeatrice Principi; Sara Onali; Chiara Viganò; Maria Cappello; Giammarco Mocci; Angelo Viscido; Giorgia Bodini; Davide Giuseppe Ribaldone; Irene Marafini; Daniela Pugliese; Alessandro Massari; Simone Saibeni; Luca Pastorelli; Laura Melotti; Irene Maria Bambina Bergna; Antonietta Gerarda Gravina; Federico Desideri; Manuela Merli; Lorenzo Bertani; Rocco Spagnuolo; Nicola Imperatore; Concetta Ferracane; Alessandro Quadarella; Imma Di Luna; Vincenza Tortorella; Silvia Mazzuoli; Carla Felice; Paola Balestrieri; Daniele Balducci; Annalisa Aratari; Andrea Buda; Silvio Danese; Franco Scaldaferri; Alessandro Armuzzi; Fabiana Zingone; Javier Chahuan; Edoardo V. Savarino
err分享
err收藏
Beyond inflammation: the residual burden as the next target in inflammatory bowel disease超越炎症：残余负担作为炎症性肠病的下一个靶点
errNature Reviews Gastroenterology & Hepatology
IF51
err2026-09-09
err0
PREAI
errBrigida Barberio; Shaji Sebastian; Alexander C. Ford; Beatriz Gros; Alessandro Armuzzi; Fernando Magro; Vipul Jairath; Edoardo V. Savarino
err分享
err收藏
IBD Nurse-Led Clinical Pathways to Optimize Patient Safety in Advanced Therapies: A Narrative Review炎症性肠病护士主导的临床路径以优化先进疗法中的患者安全：一项叙事综述
errDigestive Diseases and Sciences
IF2.5
err2026-09-07
err0
errOAAI
errDaniele Napolitano; Giuseppe Privitera; Simona Radice; Elisa Schiavoni; Greta Lorenzon; Marco Murgiano; Simone Parello; Cristina Bezzio; Gionata Fiorino; Lucrezia Laterza; Loris Riccardo Lopetuso; Alfredo Papa; Alessandro Armuzzi; Edoardo Savarino; Antonio Gasbarrini; Franco Scaldaferri
err分享
err收藏
Intestinal Ultrasound-Guided Precision Medicine in Inflammatory Bowel Diseases: A Narrative Review肠道超声引导精准医学在炎症性肠病中的应用：一项叙述性综述
errJournal of Personalized Medicine
IF3
err2026-06-24
err0
errOAAI
errCicerone Clelia; Fabrizio Fanizzi; Arianna Dal Buono; Ilaria Faggiani; Ferdinando D’Amico; Alessandra Zilli; Tommaso Lorenzo Parigi; Virginia Solitano; Federica Furfaro; Sara Massironi; Alessandro Armuzzi; Silvio Danese; Mariangela Allocca
err分享
err收藏
A decade of clinical data with vedolizumab: the past, present, and future维得利珠单抗十年临床数据：过去、现在与未来
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-25
err0
PREAI
errVipul Jairath; Alessandro Armuzzi; Christian Agboton; Brian Bressler; Silvio Danese; Parambir S. Dulai; Marlies Meyer; Itzel Romo Bautista; Raja Atreya; Brian G. Feagan
err分享
err收藏
Clinical characteristics and treatment pathways of ulcerative colitis patients with isolated proctitis in Europe and the United States欧洲和美国孤立性溃疡性直肠炎患者的临床特征及治疗路径
errTherapeutic Advances in Gastroenterology
IF3.4
err2026-05-08
err0
PREAI
errAlessandro Armuzzi; Silvio Danese; Manuel Barreiro-de Acosta; Peter Hur; Lauren Bartolome; Karolina Wosik; Hannah Knight; Vanda Palace; Laurent Peyrin-Biroulet
err分享
err收藏
Sustainable monitoring in inflammatory bowel disease: comparative carbon, energy, waste, and cost impact of intestinal ultrasound versus colonoscopy炎症性肠病中的可持续监测：肠超声与结肠镜检查在碳、能源、废物和成本影响方面的比较
errDigestive and Liver Disease
IF3.8
err2026-04-24
err0
errOAAI
errArianna Dal Buono; Roberto Gabbiadini; Giuseppe Privitera; Benedetta Masoni; Matteo Spertino; Giulia Migliorisi; Gianluca Franchellucci; Laura Loy; Alessandro Repici; Cristina Bezzio; Alessandro Armuzzi
err分享
err收藏
New Technologies for IBD Endoscopy炎症性肠病（IBD）内镜新技术
errJournal of Clinical Medicine
IF2.9
err2026-04-06
err0
errOAAI
errCristina Bezzio; Valeria Farinola; Giuseppe Privitera; Arianna Dal Buono; Roberto Gabbiadini; Laura Loy; Gianluca Franchellucci; Erica Bartolotta; Giulia Migliorisi; Alessandro Armuzzi
err分享
err收藏
Efficacy and Safety of Obefazimod in Patients With Moderately to Severely Active Ulcerative Colitis: Results From Two, Phase 3, Randomised, Double-Blind, Placebo-Controlled, 8-Week Induction Trials (ABTECT-1 and 2)奥贝非齐莫德在患有中度至重度活动性溃疡性结肠炎患者中的疗效与安全性：来自两项为期8周的诱导治疗期3期、随机、双盲、安慰剂对照试验（ABTECT-1和2）的结果
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-12-01
err0
PREAI
errSands, Bruce E.; Danese, Silvio; Peyrin-Biroulet, Laurent; Dubinsky, Marla; Hisamatsu, Tadakazu; Tilg, Herbert; Atreya, Raja; Armuzzi, Alessandro; Treton, Xavier; Baert, Filip; Seidler, Ursula; Cataldi, Fabio; Jacobstein, Doug; Rabbat, Christopher J.; Shan, Kejia; Duvall, George Aaron; Siegmund, Britta; Dulai, Parambir S.; Rubin, David; Vermeire, Severine
err分享
err收藏
Sessile Serrated Lesions in Inflammatory Bowel Disease: Hidden Players in Colitis-Associated Colorectal Cancer?炎症性肠病中的 sessile Serrated Lesions：结肠炎相关结直肠癌中的隐藏角色？
errJournal of Clinical Medicine 2025, Vol. 14, Page 8042
IF2.9
err2025-11-18
err0
errOAAI
errRoberto de Sire; Diletta De Deo; Miriana Mercurio; Gianluca Franchellucci; Giulio Calabrese; Livio Bonacci; Mauro Sollai Pinna; Cristina Bezzio; Alessandro Armuzzi; Cesare Hassan; Alessandro Repici; Fabiana Castiglione; Sandro Ardizzone; Roberta Maselli
err分享
err收藏
Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysis免疫调节剂、生物制剂和先进疗法对糖皮质激素难治性急性重度溃疡性结肠炎的疗效比较：一项网络Meta分析和时间至事件分析
errDigestive and Liver Disease
IF3.8
err2025-11-03
err0
PREAI
errMohammad Al Hayek; Mohammed S. Beshr; Mohamedhen Vall Nounou; Maria Manuela Estevinho; Maia Kayal; Catarina Frias-Gomes; Johan Burisch; Alessandro Armuzzi; Bisher Sawaf; Mulham Alom; Miguel Regueiro; Fernando Magro; Edward V. Loftus; Muhammed Elhadi
err分享
err收藏
Sequencing JAK-inhibitors in ulcerative colitis: effectiveness and safety of switching within treatment class溃疡性结肠炎中JAK抑制剂的序贯治疗：同类别转换治疗的有效性与安全性
errJournal of Crohn's and Colitis
IF8.7
err2025-11-03
err0
PREAI
errTommaso Innocenti; Jurij Hanžel; Marie Truyens; Milan Lukaš; Hannah Gordon; Anneline Cremer; Tamás Molnár; Mette Julsgaard; Sara Onali; Alessia Todeschini; Olga Maria Nardone; Nurulamin M Noor; Flavio Caprioli; Franco Scaldaferri; Konstantinos Argyriou; Edoardo Vincenzo Savarino; Marko Brinar; Charlotte R H Hedin; Milagros Vela González; Alessandro Armuzzi; Andreas Blesl; Annalisa Aratari; Alessandro Quadarella; Tommaso Lorenzo Parigi; Lorenzo Bertani; Concetta Ferracane; Mathieu Uzzan; George Michalopoulos; Alice De Bernardi; Konstantinos Katsanos; Paola Balestrieri; Gisela Piñero; Konstantinos Karmiris; Ana Gutierrez Casbas; Sara Nikolic; Carla Felice; Daniela Pugliese; Ploutarchos Pastras; Giammarco Mocci; Lieven Pouillon; Gerassimos J Mantzaris; Laura Ramos; María José Casanova; Ioannis E Koutroubakis; María José García; Triana Lobaton; Gabriele Dragoni; The JAKi-SEQ Study Group
err分享
err收藏
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age奥扎尼妥（Ozanimod）在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性
errINFLAMMATORY BOWEL DISEASES
IF4.3
err2025-11-01
err0
PREAI
errFaye, Adam S.; Rubin, David T.; Siegel, Corey A.; Long, Millie D.; Khan, Nabeel; Danese, Silvio; Irving, Peter M.; Cross, Raymond K.; Blumenstein, Irina; Armuzzi, Alessandro; Horst, Sara N.; Dignass, Axel; Kobayashi, Taku; Lawlor, Garrett; Krakovich, Anthony; Petersen, Annkatrin; Liu, Zhaohui; Wang, Dong; Jain, Anjali; Ananthakrishnan, Ashwin N.; Sabino, Joao
err分享
err收藏
Neuroendocrine tumors in patients with inflammatory bowel disease: a case series炎症性肠病患者中的神经内分泌肿瘤：一个病例系列
errEndocrine
IF2.9
err2025-10-15
err0
PREAI
errRoberta Elisa Rossi; Benedetta Masoni; Giulia Migliorisi; Cristina Bezzio; Alexia Francesca Bertuzzi; Silvia Uccella; Andrea Gerardo Antonio Lania; Alessandro Zerbi; Antonino Spinelli; Cesare Hassan; Alessandro Repici; Alessandro Armuzzi
err分享
err收藏
Variability and performance of radiologic stricture parameters in Crohn's disease: a systematic review and meta-analysis克罗恩病中放射学狭窄参数的变异性和表现：一项系统评价和荟萃分析
erreClinicalMedicine
IF10
err2025-10-08
err0
errOAAI
errArianna Dal Buono; Francesco Faita; Sarah Bencardino; Giacomo Maiucci; Alberto Barchi; Alessandro Armuzzi; Dominik Bettenworth; Silvio Danese; Mariangela Allocca
err分享
err收藏
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis炎症性肠病患者通过1年维持治疗使用vedolizumab或皮下注射infliximab因疗效不足而停药的比例：一项系统文献综述和荟萃分析
errTherapeutic Advances in Gastroenterology
IF3.4
err2025-10-08
err0
errOAAI
errMarc Ferrante; Laurent Peyrin-Biroulet; Perttu Arkkila; Alessandro Armuzzi; Jean-Frédéric Colombel; Silvio Danese; Roberto Faggiani; Jordi Guardiola; Stephen B. Hanauer; Jorgen Jahnsen; Walter Reinisch; Xavier Roblin; Philip J. Smith; Taek Sang Kwon; Seungmin Kim; Kyoungwan Nam; Raja Atreya
err分享
err收藏
Revolutionizing Crohn’s Disease Monitoring: The Emerging Role of Intestinal Ultrasound革新克罗恩病监测：肠道超声的兴起作用
errCurrent Opinion in Pharmacology
IF4.2
err2025-10-04
err0
PREAI
errCristina Bezzio; Luisa Bertin; Arianna Dal Buono; Giuseppe Privitera; Roberto Gabbiadini; Laura Loy; Alessandro Armuzzi
err分享
err收藏
Rate of Participation in a Second Randomized Clinical Trial and Factors Associated with the Likelihood of Participation among IBD Patients who already Experienced a Randomized Clinical Trial参与第二次随机临床试验的比率及与IBD患者参与可能性相关的影响因素（这些患者已参加过随机临床试验）
errCROHNS & COLITIS 360
IF0
err2025-10-01
err0
PREAI
errGabbiadini, Roberto; Pitoni, Demis; Bertoli, Peter; Privitera, Giuseppe; Dal Buono, Arianna; Danieli, Patrizia; Repici, Alessandro; Loy, Laura; Bezzio, Cristina; Armuzzi, Alessandro
err分享
err收藏
What’s new in IBD research? Refining the agenda: Outcomes, patient-centered care, and technologyIBD研究领域的新进展？完善议程：结局、以患者为中心的护理与技术
errDigestive and Liver Disease
IF3.8
err2025-09-13
err0
PREAI
errGiuseppe Privitera; Cristina Bezzio; Alessandro Armuzzi
err分享
err收藏
Upadacitinib is associated with better clinical and biochemical outcomes than tofacitinib in refractory, moderate-to-severe UC乌帕替尼（Upadacitinib）与托法替尼（tofacitinib）相比，在难治性中重度溃疡性结肠炎（UC）中表现出更优的临床和生化结局。
errClinical Gastroenterology and Hepatology
IF12
err2025-09-09
err0
PREAI
errBernadett Farkas; Tamás Resál; Peter L. Lakatos; Talat Bessissow; Jimmy K. Limdi; Alessandro Armuzzi; Cristina Bezzio; Edoardo V. Savarino; Simone Saibeni; George Michalopoulos; Mohamed Attauabi; Jakob Benedict Seidelin; Fotios S. Fousekis; Kostas Katsanos; Péter Bacsur; Anita Bálint; Emese Ivány; Zoltán Szepes; Klaudia Farkas; Tamás Molnár
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
W
William J. Sandborn
H 指数: 199 · 论文数: 2.1K
S
Stefan Schreiber
H 指数: 192 · 论文数: 1.9K
S
Séverine Vermeire
H 指数: 163 · 论文数: 2.4K
A
Antonio Gasbarrini
H 指数: 145 · 论文数: 3.8K
S
Silvio Danese
H 指数: 139 · 论文数: 2.3K
查看更多